Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Malkin

Showing results (71-80 of 270) with videos related to

Pageof 27
Sort By:
Pediatric Blood & Cancer|August 18, 2018
Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumorsCatherine Goudie, Noelle Cullinan, Anita Villani, et al.
Cancer Research|January 6, 2010
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcomaIvan Pasic, Adam Shlien, Adam D Durbin, et al.
Pediatric Blood & Cancer|January 26, 2007
Toxicity and outcome of children with treatment related acute myeloid leukemiaUri Tabori, Giselle Revach, Paul C Nathan, et al.
Cancer|January 10, 2018
Pediatric oncologist willingness to offer germline TP53 testing in osteosarcomaEliana Shaul, Michael Roth, Yungtai Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group studyJonathan D Wasserman, Ana Novokmet, Claudia Eichler-Jonsson, et al.
Paediatrics & Child Health|July 24, 2023
Precision oncology for children: A primer for paediatriciansSarah Cohen-Gogo, Avram E Denburg, Anita Villani, et al.
Pediatric Blood & Cancer|September 13, 2018
"A change in perspective": Exploring the experiences of adolescents with hereditary tumor predispositionEvan Weber, Cheryl Shuman, Jonathan D Wasserman, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growthBikul Das, Roula Antoon, Rika Tsuchida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Universal poor survival in children with medulloblastoma harboring somatic TP53 mutationsUri Tabori, Berivan Baskin, Mary Shago, et al.
Pediatric Blood & Cancer|November 12, 2005
Differentiation of rhabdomyosarcoma cell lines using retinoic acidJason W Barlow, Joe C Wiley, Marieke Mous, et al.
Pageof 27

Showing results (71-80 of 270) with videos related to

Sort By:
Pageof 27
Pediatric Blood & Cancer|August 18, 2018
Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumorsCatherine Goudie, Noelle Cullinan, Anita Villani, et al.
Cancer Research|January 6, 2010
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcomaIvan Pasic, Adam Shlien, Adam D Durbin, et al.
Pediatric Blood & Cancer|January 26, 2007
Toxicity and outcome of children with treatment related acute myeloid leukemiaUri Tabori, Giselle Revach, Paul C Nathan, et al.
Cancer|January 10, 2018
Pediatric oncologist willingness to offer germline TP53 testing in osteosarcomaEliana Shaul, Michael Roth, Yungtai Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group studyJonathan D Wasserman, Ana Novokmet, Claudia Eichler-Jonsson, et al.
Paediatrics & Child Health|July 24, 2023
Precision oncology for children: A primer for paediatriciansSarah Cohen-Gogo, Avram E Denburg, Anita Villani, et al.
Pediatric Blood & Cancer|September 13, 2018
"A change in perspective": Exploring the experiences of adolescents with hereditary tumor predispositionEvan Weber, Cheryl Shuman, Jonathan D Wasserman, et al.
Neoplasia (New York, N.Y.)|September 25, 2008
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growthBikul Das, Roula Antoon, Rika Tsuchida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Universal poor survival in children with medulloblastoma harboring somatic TP53 mutationsUri Tabori, Berivan Baskin, Mary Shago, et al.
Pediatric Blood & Cancer|November 12, 2005
Differentiation of rhabdomyosarcoma cell lines using retinoic acidJason W Barlow, Joe C Wiley, Marieke Mous, et al.
Pageof 27